The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03386877
Previous Study | Return to List | Next Study

Periodontal Regeneration Using Dental Pulp Stem Cells (DPSCs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03386877
Recruitment Status : Completed
First Posted : December 29, 2017
Last Update Posted : December 29, 2017
Sponsor:
Information provided by (Responsible Party):
Francesco Ferrarotti, University of Turin, Italy

Tracking Information
First Submitted Date  ICMJE December 15, 2017
First Posted Date  ICMJE December 29, 2017
Last Update Posted Date December 29, 2017
Actual Study Start Date  ICMJE January 25, 2016
Actual Primary Completion Date April 28, 2017   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: December 20, 2017)
Radiographic bone fill [ Time Frame: baseline and 12 months ]
Periapical standardized radiographs were taken by a clinician masked to the clinical measurements using the paralleling technique and individually customized bite-blocks (RINN XCP Film Holding Instruments, Dentsply, York, USA)
Original Primary Outcome Measures  ICMJE Same as current
Change History No Changes Posted
Current Secondary Outcome Measures  ICMJE
 (submitted: December 20, 2017)
  • Probing depth reduction [ Time Frame: baseline, 6 and 12 months ]
    Probing depth is assessed on the experimental teeth using periodontal probe (PCP 15/11.5, Hu-Friedy, Chicago, IL, USA)
  • Clinical attachment gain [ Time Frame: baseline, 6 and 12 months ]
    Clinical attachment level is assessed on the experimental teeth using periodontal probe (PCP 15/11.5, Hu-Friedy, Chicago, IL, USA)
  • Recession reduction [ Time Frame: baseline, 6 and 12 months ]
    Recession depth is assessed on the experimental teeth using periodontal probe (PCP 15/11.5, Hu-Friedy, Chicago, IL, USA)
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Periodontal Regeneration Using Dental Pulp Stem Cells (DPSCs)
Official Title  ICMJE Human Intrabony Defect Regeneration With Micro-grafts Containing Dental Pulp Stem Cells: a Randomized Controlled Clinical Trial.
Brief Summary The goal of this study is to evaluate if dental pulp stem cells (DPSCs) delivered into intrabony defects in a collagen scaffold would enhance the clinical and radiographic parameters of periodontal regeneration.
Detailed Description In this randomized controlled trial, 29 chronic periodontitis patients presenting one deep intrabony defect and requiring extraction of one vital tooth were consecutively enrolled. Defects were randomly assigned to test or control treatments which both consisted of the use of minimally invasive surgical technique. The dental pulp of the extracted tooth was mechanically dissociated to obtain micro-grafts rich in autologous DPSCs. Test sites (n=15) were filled with micro-grafts seeded onto collagen sponge, whereas control sites (n=14) with collagen sponge alone. Clinical and radiographic parameters were recorded at baseline, 6 and 12 months postoperatively.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE Periodontal Diseases
Intervention  ICMJE Procedure: periodontal regeneration
Defects were accessed with the MIST In the test group the obtained micro-grafts enriched in DPSCs were endorsed onto a collagen sponge scaffold (Condress®, Istituto Gentili, Milano, Italy) to form a bio-complex. In the control group the collagen sponge was only hydrated using physiologic sterile solution. The collagen sponge with or without cells was provided to the masked surgeon who filled the intrabony defect. The flaps were repositioned and tension-free primary flap closure was obtained using horizontal internal mattress and interrupted sutures
Study Arms  ICMJE
  • Experimental: Dental pulp stem cells
    Test sites (n=15) Periodontal regeneration using micro-grafts of Dental pulp stem cells seeded onto collagen sponge
    Intervention: Procedure: periodontal regeneration
  • Active Comparator: coagulum
    control sites (n=14) Periodontal regeneration using coagulum and collagen sponge alone
    Intervention: Procedure: periodontal regeneration
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: December 20, 2017)
29
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE April 28, 2017
Actual Primary Completion Date April 28, 2017   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • diagnosis of advanced chronic periodontitis
  • FMPS<20%
  • FMBS<20%
  • infrabony defect >2mm
  • Probing depth >5mm
  • presence of 1 vital and intact tooth requiring an extraction as autologous source of DPSCs

Exclusion Criteria:

  • smoking
  • controindicazion for periodontal surgery
  • systemic diseases affecting periodontal healing
  • pregnancy an lactation
  • fixed orthodontic appliance
  • history of periodontal surgery at the experimental teeth
  • prostethic restorations at the experimental teeth
  • furcation defects
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Italy
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03386877
Other Study ID Numbers  ICMJE UTurin stem cell RCT
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Francesco Ferrarotti, University of Turin, Italy
Original Responsible Party Same as current
Current Study Sponsor  ICMJE University of Turin, Italy
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Mario Aimetti Turin University
PRS Account University of Turin, Italy
Verification Date December 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP